A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

INTRODUCTION: We examined the neutralizing antibody production efficiency of the second and third severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine doses (2(nd)- and 3(rd)-dose) and neutralizing activity on mutant strains, including, the Ancestral, Beta and Omicron strains using g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomiyama, Takahiro, Suzuki, Rigel, Harada, Noboru, Tamura, Tomokazu, Toshida, Katsuya, Kosai-Fujimoto, Yukiko-, Tomino, Takahiro, Yoshiya, Shohei, Nagao, Yoshihiro, Takeishi, Kazuki, Itoh, Shinji, Kobayashi, Nobuhiro, Ito, Hayato, Yoshio, Sachiyo, Kanto, Tatsuya, Yoshizumi, Tomoharu, Fukuhara, Takasuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229048/
https://www.ncbi.nlm.nih.gov/pubmed/37260700
http://dx.doi.org/10.3389/fcimb.2023.1197349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229048/
https://www.ncbi.nlm.nih.gov/pubmed/37260700
http://dx.doi.org/10.3389/fcimb.2023.1197349

Ejemplares similares